Nathaniel S. Treister, DMD, DMSc
Division of Oral Medicine and Dentistry, Brigham and Women’s Hospital, Boston, USA
Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, USA
Dr. Treister is Chief of the Division of Oral Medicine and Dentistry at Brigham and Women’s Hospital and Clinical Director of Oral Medicine and Oral Oncology at the Dana-Farber/Brigham and Women’s Cancer Center in Boston, Massachusetts. Dr. Treister earned his DMD from the University of Pennsylvania School of Dental Medicine and subsequently completed his Oral Medicine and Oral Biology training at the Harvard School of Dental Medicine, where he is an Associate Professor of Oral Medicine in the Department of Oral Medicine, Infection and Immunity. He is board certified in Oral Medicine and practices at Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Boston Children’s Hospital with special interest in oral mucosal diseases, salivary gland diseases, orofacial neuropathic disorders, and oral complications in cancer patients. He has published extensively in the field of oral medicine with an emphasis on oral complications of allogeneic hematopoietic cell transplantation and oral graft-versus-host disease. He is co-principal investigator of an NIH R01 grant entitled “Long Term Oral Health Outcomes in the Chronic GVHD Consortium” and serves as site principal investigator for an NIH U01 grant entitled “Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients”.
Patient evaluation and differential diagnosis (Nathaniel Treister)
Dentists are experts in the diagnosis and management of diseases of the teeth and periodontium; however most have far less comfort when it comes to “non-dental” oral diseases. Similarly, physicians receive little if any training in dental and oral medicine and are likely to refer their patients with oral diseases to oral health care specialists. For these reasons, it is not at all uncommon for a patient to visit 5-10 doctors before receiving a correct diagnosis and appropriate treatment plan, often months to even years after the initial presentation. Dentists are responsible for providing comprehensive oral health care, and therefore must be familiar with the wide range of non-odontogenic conditions that can affect the oral cavity. This talk will provide a rational, concise, and comprehensive approach to patient evaluation and the diagnosis of oral medicine conditions.
Oral complications in cancer patients (Nathaniel Treister)
Cancer is a heterogeneous disease characterized by genetic mutations and dysregulated growth that is managed with an array of therapies including surgery, cytoreductive chemotherapy, targeted therapy, radiation therapy, and cellular and immune-based therapies. Even when cancer occurs away from the oral cavity, patients are at significant risk for developing a wide range of oral toxicities and complications. In the acute setting, such complications can interfere with the effective delivery of cancer therapy, and late complications can cause significant disability and morbidity. Dentists often play an active and important role in helping to prepare patients for cancer therapy, and cancer patients who develop oral complaints during and after therapy frequently present to their dentist for evaluation and management. It is therefore essential that dentists are familiar with contemporary clinical oncology and understand the epidemiology of oral complications in cancer patients. Participants will learn the principles of conducting dental screening and clearance prior to high risk cancer therapies and will gain familiarity with the diagnosis and management of the most common oral complications encountered in cancer patients.
Íslandsmót ehf | Suðurlandsbraut 4a | 534 7010 | firstname.lastname@example.org | kt: 500106-1740
Íslandsmót Ehf. | Suðurlandsbraut 4a | 534 7010 | email@example.com | kt: 5001061740